Stanford University researchers built coordinated multi-agent AI systems that function as virtual biotech companies, generating dozens of novel drug candidates in days instead of months. In one demons…
The University of Cambridge and biotech firm DIOSynVax Ltd announced on June 5 that a Phase I clinical trial of 39 healthy volunteers showed their AI-designed vaccine is safe, well-tolerated, and trig…
The University of Cambridge successfully tested a vaccine with an antigen designed entirely by artificial intelligence, marking the first time a computer-designed active component has been used in hum…
Researchers Thomas Izgin, Andreas Meister, and Isaac Azure developed a machine learning workflow to improve hyperparameter estimation in compartmental pandemic models, achieving 5-day COVID-19 predict…